Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $259.7K | $130.2K | $49.5K | $37.3K | $7.5K | |
| Gross Profit | $13.7K | -$788.4K | -$32.7K | -$21.3K | -$1.4K | |
| Operating Income | -$1.1M | -$1.7M | -$2.7M | -$194.1K | -$2.3M | |
| EBITDA | -$1M | -$1.6M | -$2.7M | -$184.3K | -$2.3M | |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.4M | $3.4M | $1.8M | $597.6K | $372.7K | |
| Total Assets | $2.5M | $3.8M | $2.3M | $810.1K | $464.1K | |
| Current Liabilities | $1.1M | $441.2K | $192.1K | $176.5K | $202.5K | |
| Total Liabilities | $1.1M | $643.7K | $279K | $176.5K | $214.7K | |
| Total Equity | $1.4M | $3.1M | $2M | $633.6K | $249.3K | |
| Total Debt | $348.5K | $202.4K | $86.9K | -- | $12.3K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$889.1K | -$711.3K | -$645.7K | -$272.3K | -$122K | |
| Cash From Investing | -$186.8K | -$85.4K | -$73.7K | -$73.7K | -- | |
| Cash From Financing | -$180.7K | $427K | $436K | $182K | $50K | |
| Free Cash Flow | -$1.1M | -$796.7K | -$719.4K | -$346K | -$122K | |
RemSleep Holdings, Inc. engages in the design and manufacture of medical devices and products for the treatment of sleep apnea and other respiratory conditions. Its product, DeltaWave, is a nasal-pillows type interface that treats patients with sleep apnea. The company was founded by Russell F. Bird and Thomas J. Wood on June 6, 2007 and is headquartered in Clearwater, FL.
In the current month, RMSL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RMSL average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that RemSleep Holdings, Inc. share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about RemSleep Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that RemSleep Holdings, Inc. is a Sell and believe this share price will rise from its current level to --.
The price target for RemSleep Holdings, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for RemSleep Holdings, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of RemSleep Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase RemSleep Holdings, Inc. shares.
RemSleep Holdings, Inc. was last trading at $0.0000 per share. This represents the most recent stock quote for RemSleep Holdings, Inc.. Yesterday, RemSleep Holdings, Inc. closed at $0.0017 per share.
In order to purchase RemSleep Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.